DFTX · Definium Therapeutics, Inc.
$42.63
-1.27 (-2.89%)
At close · Aug 14
Market Cap
$5.73B
Shares
134.37M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-12 | Phase 3 Voyage Topline Results: DT120 ODT in Generalized Anxiety Disorder | Event |
| 2026-08-06 | Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-22 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-22 | Phase 3 Emerge Topline Results: DT120 ODT in Major Depressive Disorder | Event |
| 2026-05-07 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-26 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.definiumtx.com/
Key facts
CIK
1813814
CUSIP
24477V105
13F (30d)
353 filings
350 filers
Visit website
Investor relations